Ultra-long-acting basal insulin(Gan And Lee Pharmaceuticals)
超长效基础胰岛素（甘李药业）
Report date: 2026/04/15 20:02:38
Base Information
Drug NameUltra-long-acting basal insulin(Gan And Lee Pharmaceuticals)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesGan & Lee Pharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesGan And Lee Pharmaceuticals, UsaGan&Lee Pharmaceuticals Shandong Co LtdGan & Lee Pharmaceuticals
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A